Visualizing Health Policy: US Public’s Perspective on Prescription Drug Costs
US Public’s Opinion of Prescription Drug Costs Download VIEW JAMA INFOGRAPHIC
View the Latest: Prescription Drugs
Filter
-
-
Visualizing Health Policy: US Public’s Perspective on Prescription Drug Costs
News ReleaseThis Visualizing Health Policy infographic examines public opinion on prescription drug costs in the United States (US). Over the past 20 years, US drug spending has increased by 330% compared to a 208% increase in total US health expenditures. A large majority (78%) of the public see drug company profits as the top contributor to higher health care spending. Lowering drug costs is the public’s top health policy priority for the US Congress. While most…
-
Visualizing Health Policy: US Public’s Perspective on Prescription Drug Costs
Other PostThis infographic examines public opinion on prescription drug costs in the United States as part of the Visualizing Health Policy infographic series, produced in partnership with the Journal of the American Medical Association (JAMA).
-
KFF Health Tracking Poll – October 2019: Health Care In The Democratic Debates, Congress, And The Courts
FeatureThis poll examines health care issues in the Democratic presidential primary , government negotiation of prescription drug prices, party trust on health care, Medicare-for-all, and the pending Texas v. US lawsuit affecting the Affordable Care Act and pre-existing condition protections.
-
Poll: Democrats Say They Are Hearing Enough From Presidential Candidates About Medicare-for-All and Expanding Coverage, But Want Them to Talk More about Health Costs and Women’s Health Care
News ReleaseHeading into tonight’s Democratic primary debate, most Democrats and Democratic-leaning independents say the candidates are spending the right amount or too much time talking about ways to provide coverage to more Americans and Medicare-for-all, two topics that have dominated health care discussions in the past three rounds of Democratic debates, the latest KFF Health Tracking Poll finds. In contrast, large shares of Democrats and Democratic-leaning independents say that the presidential candidates are spending too little…
-
Medicare Part D Beneficiaries Who Reach the Catastrophic Coverage Limit Can Expect to Pay More Out-of-Pocket for Their Prescription Drugs Next Year
News ReleaseMedicare Part D enrollees with relatively high out-of-pocket expenses can expect see their costs rise in 2020, according to a new KFF analysis. This is mainly due to an increase in how much enrollees will pay out of pocket for their prescription drugs in the Part D benefit coverage gap phase before they qualify for catastrophic coverage. The analysis finds that out-of-pocket drug costs will increase by nearly $400 -- from $2,275 in 2019 to…
-
How Will The Medicare Part D Benefit Change Under Current Law and Leading Proposals?
Issue BriefThis brief describes how the Medicare Part D benefit will change in 2020 under current law and proposed changes that would affect what beneficiaries, plans, manufacturers, and Medicare pay for drug costs under Part D in the future.
-
Kaiser Health News (KHN) Wins Prestigious Barlett & Steele Investigative Journalism Award
News ReleaseKFF is pleased to announce that Kaiser Health News (KHN), its editorially independent health news service, won a top prize in the 13th annual Barlett & Steele Awards for Investigative Journalism.
-
2019 Employer Health Benefits Survey
ReportAnnual premiums for employer-sponsored family health coverage reached $20,576 this year, up 5% from last year, with workers on average paying $6,015 toward the cost of their coverage. The average deductible among covered workers in a plan with a general annual deductible is $1,655 for single coverage. Fifty-six percent of small firms and 99% of large firms offer health benefits to at least some of their workers, with an overall offer rate of 57%.
-
Data Note: Prescription Drugs and Older Adults
Issue BriefThis data note explores the attitudes and experiences of older adults, ages 65 and up, when it comes to prescription drugs and related policy proposals being discussed. Experiences across different demographic groups are explored, such as household income and health status.